MedTrace Logo

Post Marketing Clinical Follow up Study for MagnetOs Putty in Patients With Degenerative Disc Disease

NCT04128852 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-02-13

No results posted yet for this study

Summary

This study is a post-marketing clinical follow-up study for MagnetOs Putty. MagnetOs Putty is a synthetic bone-like material which is routinely used by surgeons as a treatment for patients with degenerative disc disease who will undergo surgery for spinal fusion (extreme lateral interbody fusion (XLIF). MagnetOs Putty will be used according to the instructions for use.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

MagnetOs Putty

MagnetOs Putty has a CE-mark (2115660CE01) as well as FDA 510(k) clearance (K171563/K181958).

Sponsors & Collaborators

  • Factory CRO

    collaborator INDUSTRY

  • The London Clinic

    collaborator OTHER

  • Kuros BioSciences B.V.

    collaborator INDUSTRY

  • Kuros Biosurgery AG

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-11
Primary Completion
2022-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04128852 on ClinicalTrials.gov